Announced Wed, 30 Sept, 2026 · 11:37 IST
Trading Window Closed for Insiders Ahead of Q2 Results
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.4%1-day move
₹2084.80
prior close
₹2053.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.3+0.5+0.4-1.4-3.1-4.1-4.5-7.9—————
Up moveDown movePending
AI summary
Beta Drugs Limited has closed its trading window for directors, officers, designated employees, and their immediate relatives starting 1st October 2026. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter and half year ended 30th September 2026. This is a routine compliance measure under SEBI Insider Trading Regulations.
Likely market impact
Routine compliance filing. No direct impact on shareholders. Signals upcoming Q2 results announcement.